All In Biotech

Drug Trial Radar · NCT06720025

Study of SAL-0951 Compared to Recombinant Human Erythropoietin in Anemic Patients Receiving Maintenance Hemodialysis

A Phase 3 Study to Compare the Efficacy and Safety of SAL-0951 With Recombinant Human Erythropoietin Injection in Anemic Patients With Chronic Kidney Disease Receiving Maintenance Hemodialysis <Switch / Maintenance Study>

Last checked: Nov 20, 2026Latest source record: Dec 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

100

Actual

Start

Sep 19, 2023

Primary completion

Jun 17, 2024

Study completion Jun 20, 2024

Sponsor

Sponsor type
Industry
First posted
Dec 6, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and efficacy of SAL-0951 in Chinese patients undergoing maintenance hemodialysis with chronic kidney disease and anemia,who are receiving stable treatment with erythropoietic stimulants (ESAs).

Conditions

  • Anemia

Interventions

  • SAL-0951 tabletsDrug

    initial phase:4mg QD subsequent phase:1mg~8mg QD,adjust the dose based on hemoglobin concentration level every 4 weeks

  • rHuEPO injectionDrug

    Initial based on the original rHuEPO dose adjust the dose based on hemoglobin concentration level every 4 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Difference in mean hemoglobin (Hb) level between arms during the evaluation period after treatment (non-inferiority margin: -10 g/L)Time frame: weeks 20, 22, and 24

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Sun Yat-sen University

    Guangzhou, Guangdong, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.